PENICILLAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Penicillamine, and what generic alternatives are available?
Penicillamine is a drug marketed by Apotex, Breckenridge, Dr Reddys, Endo Operations, Granules, Invagen Pharms, Navinta Llc, Watson Labs Inc, Lupin Ltd, and Teva Pharms Usa. and is included in eleven NDAs.
The generic ingredient in PENICILLAMINE is penicillamine. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the penicillamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Penicillamine
A generic version of PENICILLAMINE was approved as penicillamine by WATSON LABS INC on June 24th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PENICILLAMINE?
- What are the global sales for PENICILLAMINE?
- What is Average Wholesale Price for PENICILLAMINE?
Summary for PENICILLAMINE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 17 |
| Patent Applications: | 3,592 |
| Drug Prices: | Drug price information for PENICILLAMINE |
| What excipients (inactive ingredients) are in PENICILLAMINE? | PENICILLAMINE excipients list |
| DailyMed Link: | PENICILLAMINE at DailyMed |
Recent Clinical Trials for PENICILLAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Nanfang Hospital, Southern Medical University | Phase 2 |
| Alexion Pharmaceuticals | Phase 2 |
| Second Affiliated Hospital, School of Medicine, Zhejiang University | Early Phase 1 |
Pharmacology for PENICILLAMINE
| Drug Class | Antirheumatic Agent |
Medical Subject Heading (MeSH) Categories for PENICILLAMINE
Anatomical Therapeutic Chemical (ATC) Classes for PENICILLAMINE
US Patents and Regulatory Information for PENICILLAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 213310-001 | Apr 28, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Navinta Llc | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 214363-001 | Oct 8, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Endo Operations | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 211231-001 | Dec 23, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
